Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Ethinyl Estradiol; Levonorgestrel Patent Expiration

Ethinyl Estradiol; Levonorgestrel is Used for preventing pregnancy in women using oral contraceptives. It was first introduced by Teva Branded Pharmaceutical Products R And D Inc in its drug Nordette-21 on May 10, 1982. Other drugs containing Ethinyl Estradiol; Levonorgestrel are Nordette-28, Triphasil-28, Seasonale, Lybrel, Levlite, Preven Emergency Contraceptive Kit, Tyblume, Loseasonique, Balcoltra, Quartette, Twirla, Alesse, Seasonique, Triphasil-21. 24 different companies have introduced drugs containing Ethinyl Estradiol; Levonorgestrel.


Ethinyl Estradiol; Levonorgestrel Patents

Given below is the list of patents protecting Ethinyl Estradiol; Levonorgestrel, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Quartette US8415332 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens Mar 11, 2029 Teva Branded Pharm
Loseasonique US7855190 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration Dec 05, 2028 Teva Branded Pharm
Seasonique US7855190 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration Dec 05, 2028 Teva Branded Pharm
Twirla US8246978 Dermal delivery device with reduced loss of its volatile components Aug 26, 2028 Agile
Twirla US8747888 Dermal delivery device with in situ seal Jul 10, 2028 Agile
Twirla US9050348 Dermal delivery device Jul 10, 2028 Agile
Balcoltra US7838042 Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions Jun 01, 2027 Avion Pharms
Quartette US8450299 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens Oct 07, 2025 Teva Branded Pharm
Seasonique US7320969 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Jan 30, 2024

(Expired)

 Teva Branded Pharm
Loseasonique US7858605 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Jun 23, 2023

(Expired)

 Teva Branded Pharm
Seasonique US7858605 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Jun 23, 2023

(Expired)

 Teva Branded Pharm
Loseasonique US7615545 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Jun 15, 2023

(Expired)

 Teva Branded Pharm
Seasonique US7615545 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology Jun 15, 2023

(Expired)

 Teva Branded Pharm
Balcoltra US6716814 Enhancing solubility of iron amino acid chelates and iron proteinates Aug 16, 2021

(Expired)

 Avion Pharms
Twirla US7045145 Transdermal contraceptive delivery system and process Mar 14, 2021

(Expired)

 Agile
Twirla US7384650 Skin permeation enhancement composition for transdermal hormone delivery system Mar 14, 2021

(Expired)

 Agile
Twirla US8221784 Transdermal hormone delivery system: compositions and methods Mar 14, 2021

(Expired)

 Agile
Twirla US8221785 Transdermal hormone delivery system: compositions and methods Mar 14, 2021

(Expired)

 Agile
Preven Emergency Contraceptive Kit US6156742 Emergency contraceptive kit Dec 05, 2020

(Expired)

 Teva Branded Pharm
Twirla US8883196 Transdermal hormone delivery system: compositions and methods Nov 22, 2020

(Expired)

 Agile
Lybrel US6500814 Hormonal contraceptive Sep 03, 2018

(Expired)

 Wyeth Pharms Inc
Seasonale US5898032 Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy Jun 23, 2017

(Expired)

 Teva Branded Pharm
Seasonale USRE39861 Methods of extended use oral contraception Jun 23, 2017

(Expired)

 Teva Branded Pharm



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ethinyl Estradiol; Levonorgestrel's patents.

Given below is the list recent legal activities going on the following patents of Ethinyl Estradiol; Levonorgestrel.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed
Critical
 04 Mar, 2024 US8221785
Maintenance Fee Reminder Mailed
Critical
 04 Mar, 2024 US8221784
Payment of Maintenance Fee, 12th Yr, Small Entity 21 Feb, 2024 US8246978
Expire Patent
Critical
 19 Dec, 2022 US8883196
Payment of Maintenance Fee, 8th Yr, Small Entity 09 Dec, 2022 US9050348
Maintenance Fee Reminder Mailed
Critical
 04 Jul, 2022 US8883196
Payment of Maintenance Fee, 8th Year, Large Entity 18 Nov, 2020 US8450299(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 05 Oct, 2020 US8415332(Litigated)
Payment of Maintenance Fee, 8th Yr, Small Entity 21 Feb, 2020 US8246978
Payment of Maintenance Fee, 8th Yr, Small Entity 17 Jan, 2020 US8221784


Ethinyl Estradiol; Levonorgestrel's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ethinyl Estradiol; Levonorgestrel Generic API Manufacturers

Several generic applications have been filed for Ethinyl Estradiol; Levonorgestrel. The first generic version for Ethinyl Estradiol; Levonorgestrel was by Watson Laboratories Inc and was approved on Dec 13, 1993. And the latest generic version is by Lupin Ltd and was approved on Feb 15, 2024.

Given below is the list of companies who have filed for Ethinyl Estradiol; Levonorgestrel generic, along with the locations of their manufacturing plants worldwide.


1. AMNEAL PHARMS

Amneal Pharmaceuticals Of New York Llc has filed for 3 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. All of these versions come by the name LEVONORGESTREL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.02MG; 0.1MG

tablet Discontinued ORAL-28 N/A Feb 5, 2014
0.03MG; 0.15MG

tablet Prescription ORAL AB Nov 13, 2015
0.03MG,0.01MG; 0.15MG,N/A

tablet Prescription ORAL AB Dec 22, 2015





2. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg;0.15mg version comes by the name AYUNA, 0.02mg;0.1mg version comes by the name AFIRMELLE, 0.03mg,0.01mg;0.15mg,n/a version comes by the name SIMPESSE, 0.02mg,0.1mg;0.01mg,n/a version comes by the name LO SIMPESSE. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.03MG; 0.15MG

tablet Prescription ORAL-28 AB Sep 23, 2016
0.02MG; 0.1MG

tablet Prescription ORAL-28 AB1 Nov 14, 2016
0.03MG,0.01MG; 0.15MG,N/A

tablet Prescription ORAL AB Apr 7, 2017
0.02MG,0.1MG; 0.01MG,N/A

tablet Prescription ORAL AB Apr 28, 2017


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





3. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 1 generic for Ethinyl Estradiol; Levonorgestrel. This 0.03mg;0.15mg version comes by the name ICLEVIA. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.03MG; 0.15MG

tablet Prescription ORAL AB Jun 29, 2018


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





4. BARR

Barr Laboratories Inc has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.02mg;0.1mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.03mg;0.15mg version comes by the name PORTIA-21. Given below are the details of the strengths of this generic introduced by Barr.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.02MG; 0.1MG

tablet Discontinued ORAL-21 N/A Apr 29, 2003
0.03MG; 0.15MG

tablet Discontinued ORAL-21 N/A May 23, 2002


Manufacturing Plant Locations
New

Barr's manufacturing plants are situated in 4 countries - Mexico, Singapore, United States, Philippines. Given below are the details of these plant locations as well as the firm names of Barr as present at those locations.

Country City Firm Name
Mexico
Aldama Barra La Coma, S. De R.L
Singapore
Singapore Barramundi Asia Pte Ltd
United States
Madison Barriques Holding Company, LLC
Buffalo Barrel and Brine Inc
Englewood Barrett E. Cowan, MD
Hereford Barrett and Crofoot Feedyard, West
Greenwood Barr Enterprises, Inc.
Lake Barrington Barrington Ventures, Ltd
Arecibo Barreto Dairy, Inc.
Live Oak Barrington Dairy Farm
Brainerd Barrett Ag Service, Inc.
Commerce Barreras Meat Co
Barrett Barrett Farm Supply, Inc.
Lee Barrington Coffee Roasting Company, Inc.
Belvidere Barred Woods, LLC
Paso Robles Barreto Cellars
Somerset Barrett Distribution Centers Inc
Franklin Barrett Distribution Centers, Inc.
Forest Barr Laboratories Inc.
Memphis Barrett Distribution Centers
Machipongo Barrier Island Seafood
Swartz Creek Barrett Donut Mixes, Inc..
Curtis Bay Barrett Distribution Center
Newton Barrett Technology, LLC
Dillon Barretts Minerals Inc
Davie Barrier Technologies LLC
Montezuma Barrington Dairies
Hereford Barrett and Crofoot, LLP
Harrison Barrington Chemical Corporation
Randolph Barrett Farm
Philippines
Bulacan Barrio Fiesta Manufacturing Corporation





5. DR REDDYS LABS SA

Dr Reddys Laboratories Sa has filed for 5 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg;0.15mg version comes by the name LEVORA 0.15/30-28, 0.03mg,0.04mg,0.03mg;0.05mg,0.075mg,0.125mg version comes by the name TRIVORA-21, 0.02mg;0.1mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.03mg,0.01mg;0.15mg,n/a version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, 0.02mg,0.1mg;0.01mg,n/a version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.03MG; 0.15MG

(reference standard)

tablet Prescription ORAL-28 AB Dec 13, 1993
0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG

tablet Discontinued ORAL-21 N/A Dec 18, 1997
0.02MG; 0.1MG

(reference standard)

tablet Prescription ORAL-28 AB2 May 31, 2006
0.03MG,0.01MG; 0.15MG,N/A

tablet Prescription ORAL AB May 31, 2011
0.02MG,0.1MG; 0.01MG,N/A

tablet Discontinued ORAL N/A Oct 25, 2011





6. DURAMED PHARMS BARR

Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.02mg;0.1mg version comes by the name AVIANE-28, 0.03mg,0.04mg,0.03mg;0.05mg,0.075mg,0.125mg version comes by the name ENPRESSE-28. Given below are the details of the strengths of this generic introduced by Duramed Pharms Barr.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.02MG; 0.1MG

tablet Prescription ORAL-28 AB1 Apr 30, 2001
0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG

tablet Prescription ORAL-28 AB Jul 16, 2001





7. ENDO OPERATIONS

Endo Operations Ltd has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.02mg;0.1mg version comes by the name ORSYTHIA, 0.03mg,0.04mg,0.03mg;0.05mg,0.075mg,0.125mg version comes by the name MYZILRA. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.02MG; 0.1MG

tablet Discontinued ORAL-28 N/A May 11, 2011
0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG

tablet Prescription ORAL-28 AB Nov 23, 2011





8. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg;0.15mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.03mg,0.01mg;0.15mg,n/a version comes by the name ASHLYNA, 0.02mg;0.09mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.03MG; 0.15MG

tablet Prescription ORAL AB Jun 12, 2015
0.03MG,0.01MG; 0.15MG,N/A

tablet Prescription ORAL AB Feb 23, 2015
0.02MG; 0.09MG

tablet Prescription ORAL AB Apr 9, 2015





9. HETERO LABS

Hetero Labs Ltd has filed for 1 generic for Ethinyl Estradiol; Levonorgestrel. This 0.02mg;0.1mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Hetero Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.02MG; 0.1MG

tablet Prescription ORAL-28 AB1 Feb 13, 2023


Manufacturing Plant Locations
New

Hetero Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Hetero Labs as present at those locations.

Country City Firm Name
India
Visakhapatnam Hetero Labs Ltd. - Unit IX
Mahabubnagar Hetero Labs Limited (Unit V)
Sangareddy Hetero Labs Limited
Mahaboob Nagar Hetero Labs Ltd. Unit VI
Sanath Nagar Hetero Labs Ltd
Hyderabad Hetero Labs Limited - Unit III
Bodugallam Hetero Labs Limited (Unit III)





10. LUPIN LTD

Lupin Ltd has filed for 6 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.02mg,0.1mg;0.01mg,n/a version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, 0.03mg;0.15mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.02mg;0.1mg version comes by the name MINZOYA, 0.03mg,0.01mg;0.15mg,n/a version comes by the name DAYSEE, 0.03mg,0.04mg,0.03mg;0.05mg,0.075mg,0.125mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.02mg,0.15mg;0.025mg,0.15mg;0.03mg,0.15mg;0.01mg,n/a version comes by the name FAYOSIM. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.02MG,0.1MG; 0.01MG,N/A

tablet Prescription ORAL AB Oct 26, 2011
0.03MG; 0.15MG

tablet Prescription ORAL AB Oct 23, 2012
0.02MG; 0.1MG

tablet Prescription ORAL AB3 Feb 15, 2024
0.03MG,0.01MG; 0.15MG,N/A

tablet Prescription ORAL AB Apr 10, 2013
0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG

tablet Prescription ORAL-28 AB Nov 19, 2015
0.02MG,0.15MG; 0.025MG,0.15MG; 0.03MG,0.15MG; 0.01MG,N/A

tablet Discontinued ORAL N/A Mar 29, 2016


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





11. NAARI PTE LTD

Naari Pte Ltd has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. All of these versions come by the name LEVONORGESTREL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Naari Pte Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.02MG; 0.1MG

tablet Prescription ORAL-28 AB1 Aug 17, 2020
0.03MG; 0.15MG

tablet Prescription ORAL-28 AB Oct 9, 2020





12. NOVAST LABS

Novast Laboratories Ltd has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg;0.15mg version comes by the name SETLAKIN, 0.02mg;0.09mg version comes by the name DOLISHALE. Given below are the details of the strengths of this generic introduced by Novast Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.03MG; 0.15MG

tablet Prescription ORAL AB Sep 15, 2014
0.02MG; 0.09MG

tablet Prescription ORAL AB Oct 22, 2020





13. NOVAST LABS LTD

Novast Laboratories Ltd has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg,0.04mg,0.03mg;0.05mg,0.075mg,0.125mg version comes by the name LEVONEST, 0.02mg;0.1mg version comes by the name FALMINA. Given below are the details of the strengths of this generic introduced by Novast Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG

tablet Prescription ORAL-28 AB Dec 29, 2010
0.02MG; 0.1MG

tablet Prescription ORAL-28 AB1 Mar 28, 2012





14. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.02mg;0.1mg version comes by the name CERINTA, 0.03mg;0.15mg version comes by the name SYLEVIA. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.02MG; 0.1MG

tablet Discontinued ORAL-28 N/A Jan 7, 2019
0.03MG; 0.15MG

tablet Discontinued ORAL N/A Feb 6, 2019


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Lexington Sun Pharmaceutical Industries Inc
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
Billerica Sun Pharmaceutical Industries, Inc.
India
Vadodara Sun Pharmaceutical Industries Ltd.
Vadodara Sun Pharmaceutical Industries Ltd
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Halol Sun Pharmaceutical Industries Ltd.
New Delhi Sun Pharmaceutical Industries Limited
Punjab Sun Pharmaceutical Industries, Inc.
Mohali Sun Pharmaceutical Industries Limited
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Bharuch Sun Pharmaceutical Industries Ltd
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Ahmednagar Sun Pharmaceutical Industries Limited
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Dadra Sun Pharmaceutical Industries Limited
Baruch Sun Pharmaceutical Industries Ltd.





15. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg;0.15mg version comes by the name QUASENSE, 0.02mg;0.09mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.03MG; 0.15MG

tablet Prescription ORAL AB Sep 6, 2006
0.02MG; 0.09MG

(reference standard)

tablet Prescription ORAL AB Jun 6, 2011





16. XIROMED

Xiromed Pharma Espana Sl has filed for 6 different strengths of generic version for Ethinyl Estradiol; Levonorgestrel. Out of these 0.03mg;0.15mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.02mg;0.1mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, 0.03mg,0.01mg;0.15mg,n/a version comes by the name JAIMIESS, 0.02mg,0.1mg;0.01mg,n/a version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, 0.03mg,0.04mg,0.03mg;0.05mg,0.075mg,0.125mg version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL, 0.02mg,0.15mg;0.025mg,0.15mg;0.03mg,0.15mg;0.01mg,n/a version comes by the name LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL. Given below are the details of the strengths of this generic introduced by Xiromed.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.03MG; 0.15MG

tablet Prescription ORAL AB Apr 21, 2015
0.02MG; 0.1MG

tablet Prescription ORAL AB3 Aug 16, 2023
0.03MG,0.01MG; 0.15MG,N/A

tablet Prescription ORAL AB Dec 27, 2017
0.02MG,0.1MG; 0.01MG,N/A

tablet Prescription ORAL AB Dec 14, 2017
0.03MG,0.04MG,0.03MG; 0.05MG,0.075MG,0.125MG

tablet Discontinued ORAL-28 N/A Mar 23, 2018
0.02MG,0.15MG; 0.025MG,0.15MG; 0.03MG,0.15MG; 0.01MG,N/A

tablet Prescription ORAL AB Oct 2, 2017


Manufacturing Plant Locations
New

Xiromed's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Xiromed as present at those locations.

Country City Firm Name
United States
Florham Park XIROMED LLC